社会经济地位影响难治性慢性鼻窦炎术后生产力损失和健康效用变化
前瞻性多机构队列研究纳入229例接受内镜鼻窦手术的成人慢性鼻窦炎患者,163例(71%)有术后随访。全体患者术后平均货币化生产力损失和健康效用值均显著改善(均p<0.001)。最低收入(≤25,000美元/年)和Medicare保险患者未报告显著改善(生产力损失p≥0.112,健康效用值p≥0.081),而较高收入层和雇主提供/私人保险者显著改善(均p≤0.003)。
要点
- 全体患者术后平均货币化生产力损失和健康效用值均显著改善(均p<0.001)。
- 最低收入(≤25,000美元/年)和Medicare保险患者未报告显著改善(生产力损失p≥0.112,健康效用值p≥0.081)。
- 较高收入层(25,001至100,000美元/年和100,001+美元/年)及雇主提供/私人保险者显著改善(均p≤0.003)。
核心结论
- 包括收入和保险提供在内的社会经济因素可能影响内镜鼻窦手术后生产力损失和健康效用值的改善。
- 需要进一步研究来验证这些发现、明确这些结果背后的机制并改善这些结局。
研究设计与样本
- 前瞻性多机构队列研究,纳入229例≥18岁接受内镜鼻窦手术的慢性鼻窦炎成人患者,163例(71%)提供术后随访。
- 生产力损失采用人力资本法计算,并使用美国政府估计的工资率货币化;健康效用值源自医学结局研究简表-12调查,使用谢菲尔德大学算法得出。
- 感兴趣的社会经济因素包括年龄、性别、种族、保险状态、教育程度和按Thompson-Hickey模型分类的家庭收入。
主要发现
- 所有受试者术后平均货币化生产力损失(p < 0.001)和健康效用值(p < 0.001)均报告显著的个体内改善。
- 最低收入(≤25,000美元/年)和Medicare保险患者未报告生产力损失(p ≥ 0.112)或健康效用值(p ≥ 0.081)的显著改善,尽管样本量限制可能促成此发现。
- 较高收入层(25,001至100,000美元/年和100,001+美元/年)及雇主提供/私人健康保险者报告术后生产力损失和健康效用值显著改善(均p ≤ 0.003)。
局限性
- 样本量限制可能促成了最低收入和Medicare保险患者未报告显著改善这一发现。
- 需要进一步研究来验证这些发现、明确这些结果背后的机制并改善这些结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Social determinants of health can have a substantial impact on treatment outcomes. Prior study has shown that socioeconomic status influences the likelihood of improvement in quality-of-life (QOL) following endoscopic sinus surgery (ESS). However, the impact of socioeconomic factors on changes in productivity loss and health utility after ESS remains unknown. METHODS: Adult patients (≥18 years of age) with chronic rhinosinusitis (CRS) who underwent ESS were prospectively enrolled into a multi-institutional cohort study. Productivity losses were calculated using the human capital approach and monetized using U.S. government-estimated wage rates. Health utility values (HUVs) were derived from the Medical Outcomes Study Short-Form-12 survey using University of Sheffield algorithms. Independent socioeconomic factors of interest included: age, gender, ethnicity, insurance status, educational attainment, and household income categorized via the Thompson-Hickey model. RESULTS: A total of 229 patients met inclusion criteria, and 163 (71%) provided postoperative follow-up. All subjects reported significant, within-subject improvement in both mean monetized productivity loss (p < 0.001) and HUV postoperatively (p < 0.001). Using paired sample statistics, patients with lowest income (≤$25,000/year) and with Medicare insurance did not report significant improvement in productivity loss (p ≥ 0.112) or HUV (p ≥ 0.081), although sample size limitations may have contributed to this finding. Patients in higher income tiers ($25,001 to $100,000/year and $100,001+/year) and those with employer-provided/private health insurance reported significant postoperative improvements in productivity loss and HUV (all p ≤ 0.003). CONCLUSION: Socioeconomic factors, including income and insurance provision, may impact improvements in productivity loss and HUV following ESS. Further research to validate these findings, ascertain mechanisms behind these results, and improve these outcomes is warranted.
引用
- Beswick DM, Mace JC, Soler ZM, et al. Socioeconomic status impacts postoperative productivity loss and health utility changes in refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019. PMID: 31246360. doi:10.1002/alr.22374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。